About: COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System. Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System.
Creator	Abboud, Hilal Arkha, Yasser Kharbouch, Hanane Ouahabi, Abdessamad Zahra, Fatima Abbadi, Najia Abboud, Fatima El, Najia
Source	Elsevier; Medline; PMC
abstract	Coronavirus disease 19 (COVID-19) is an infectious disease caused by SARS-Cov-2, resulting in severe acute respiratory syndrome, with high potential of spreading and infecting humans worldwide. Since January 2020, when the virus was identified in humans, the literature on COVID-19 has grown exponentially, and extra respiratory symptoms including neurological symptoms are increasingly highlighted. These neurological disorders are grouped into several categories, ranging from non-specific and moderate symptoms such as headache, myalgia and hyposmia to severe symptoms including cerebrovascular disease and intracranial infections. Severe neurological symptoms such as acute cerebrovascular disease occur only in a minority of patients with usual risk factor, and are associated with poor outcome. However, most COVID-19 patients exhibit only minor or mild neurological symptoms. Given the high and increasing number of publications reporting neurological involvements of SARS-Cov-2, we think providing an update for neurological complications of COVID-19 could be useful for physician and especially young trainees in neurology and neurosurgery. Indeed, in this review we discuss several neurological aspects reported in the literature to date, including the evidence and pathways of the neuro-invasion in COVID-19, and the main neurological disorders reported in the literature to date, as well as the future perspectives and the potential long term consequence of current neuro-infection in COVID-19 patients.
has issue date	2020-05-28(xsd:dateTime)
bibo:doi	10.1016/j.wneu.2020.05.193
bibo:pmid	32474093
has license	els-covid
sha1sum (hex)	e410c19e6a2e6987ea3f8e8a5ca9cd4c26e2456d
schema:url	https://doi.org/10.1016/j.wneu.2020.05.193
resource representing a document's title	COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System.
has PubMed Central identifier	PMC7255736
has PubMed identifier	32474093
schema:publication	World Neurosurg
resource representing a document's body	covid:e410c19e6a2e6987ea3f8e8a5ca9cd4c26e2456d#body_text
is schema:about of	named entity 'CEREBROVASCULAR DISEASE' named entity 'MINOR' named entity 'NEUROLOGY' named entity 'SEVERE ACUTE RESPIRATORY SYNDROME' named entity 'COVID-19' named entity 'INCLUDING' named entity 'POTENTIAL' named entity 'CONSEQUENCE OF' named entity 'INVOLVEMENTS' named entity 'GROUPED' named entity 'HYPOSMIA' named entity 'OCCUR' named entity 'TRAINEES' named entity 'ASSOCIATED WITH' named entity 'LITERATURE' named entity 'UPDATE' named entity 'INFECTIONS' named entity 'SARS-Cov-2' named entity 'SARS-CoV' named entity 'neurological complications' named entity 'non-specific symptoms' named entity 'hiccups' named entity 'olfactory dysfunction' named entity 'Coronaviruses' named entity 'hypertension' named entity 'symptom' named entity 'SARS-CoV' named entity 'ACE2' named entity 'SARS-CoV-2' named entity 'Intra-cerebral haemorrhage' named entity 'intracranial haemorrhage' named entity 'liver problems' named entity 'COVID-19' named entity 'host cells' named entity 'SARS-CoV-2' named entity 'COVID' named entity 'cerebrospinal fluid' named entity 'COVID-19' named entity 'GBS' named entity 'risk factors' named entity 'neuralgia' named entity 'sense of smell' named entity 'acute infection' named entity 'Interleukin-15' named entity 'SARS-Cov-2' named entity 'encephalitis' named entity 'COVID-19' named entity 'D-dimer' named entity 'Hyposmia' named entity 'neurological symptoms' named entity 'infecting humans' named entity 'COVID' named entity 'cerebrovascular disease' named entity 'hyposmia' named entity 'headache' named entity 'long term' named entity 'Infection' named entity 'SARS-Cov-2' named entity 'cell entry' named entity 'COVID' named entity 'metabolic' named entity 'multi-organ failure' named entity 'macrophages' named entity 'neurological complications' named entity 'fatigue' named entity 'electrolyte' named entity 'cerebrospinal fluid' named entity 'prognosis' named entity 'hypercoagulability' named entity 'Guillain Barre Syndrome' named entity 'thrombocytopenia' named entity 'virus' named entity 'endothelium' named entity 'SARS-CoV'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software